Blockade of TRPV2 is a Novel Therapy for Cardiomyopathy in Muscular Dystrophy.
TRPV2
TRPV2 inhibitors
cardiomyopathy
heart failure
muscular dystrophy
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
07 Aug 2019
07 Aug 2019
Historique:
received:
27
06
2019
revised:
16
07
2019
accepted:
02
08
2019
entrez:
10
8
2019
pubmed:
10
8
2019
medline:
7
1
2020
Statut:
epublish
Résumé
Muscular dystrophy and dilated cardiomyopathy are intractable diseases and their treatment options are very limited. Transient receptor potential cation channel subfamily V, member 2 (TRPV2), is a stretch-sensitive Ca
Identifiants
pubmed: 31394715
pii: ijms20163844
doi: 10.3390/ijms20163844
pmc: PMC6720432
pii:
doi:
Substances chimiques
TRPV Cation Channels
0
TRPV2 protein, human
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Japan Society for the Promotion of Science
ID : 18K07544
Organisme : Grant-in-Aid for Research on Nervous and Mental Disorders of NCNP
ID : 28-6
Références
J Biol Chem. 2001 Feb 16;276(7):4647-51
pubmed: 11029464
Am J Physiol Cell Physiol. 2001 Aug;281(2):C690-9
pubmed: 11443068
J Exp Med. 2002 Feb 4;195(3):375-81
pubmed: 11828013
J Cell Biol. 2003 Jun 9;161(5):957-67
pubmed: 12796481
Biochem Pharmacol. 2005 Sep 1;70(5):740-51
pubmed: 16009351
Circ Res. 2007 Jul 20;101(2):185-94
pubmed: 17556660
Mol Pharmacol. 2007 Nov;72(5):1258-68
pubmed: 17673572
Hum Mol Genet. 2009 Mar 1;18(5):824-34
pubmed: 19050039
FEBS Lett. 2009 Nov 19;583(22):3600-4
pubmed: 19840792
J Neurosci. 2010 Dec 8;30(49):16536-44
pubmed: 21147993
Physiol Res. 2012;61(1):113-24
pubmed: 21574765
Proc Jpn Acad Ser B Phys Biol Sci. 2011;87(8):550-62
pubmed: 21986317
Neuromuscul Disord. 2012 Nov;22(11):1006-14
pubmed: 22749475
J Am Coll Cardiol. 2013 Feb 5;61(5):582-8
pubmed: 23273396
Cardiovasc Res. 2013 Sep 1;99(4):760-8
pubmed: 23786999
PLoS One. 2014 Aug 19;9(8):e105055
pubmed: 25136832
Pharmacol Res. 2015 Jan;91:15-28
pubmed: 25447595
Cardiovasc Res. 2015 Apr 1;106(1):153-62
pubmed: 25616416
Cell Calcium. 2016 Apr;59(4):145-155
pubmed: 26803937
J Cachexia Sarcopenia Muscle. 2016 Jun;7(3):366-76
pubmed: 27239414
Data Brief. 2016 Aug 10;8:1443-7
pubmed: 27617280
Aging Clin Exp Res. 2017 Oct;29(5):863-873
pubmed: 27804106
J Hypertens. 2017 Mar;35(3):602-611
pubmed: 28009703
PLoS One. 2017 May 8;12(5):e0177132
pubmed: 28481959
Prog Biophys Mol Biol. 2017 Nov;130(Pt B):273-280
pubmed: 28546113
Circ Res. 2017 Sep 15;121(7):731-748
pubmed: 28912180
Intern Med. 2018 Feb 1;57(3):311-318
pubmed: 29093384
EMBO Mol Med. 2018 Apr;10(4):
pubmed: 29531021
Oncotarget. 2018 Feb 8;9(18):14042-14057
pubmed: 29581825
J Med Chem. 2018 Sep 27;61(18):8255-8281
pubmed: 30176215
J Med Chem. 2019 Feb 14;62(3):1373-1384
pubmed: 30620187
Cell. 1995 Mar 10;80(5):675-9
pubmed: 7889563
J Cell Biol. 1993 Aug;122(4):809-23
pubmed: 8349731
FEBS Lett. 1993 Aug 23;329(1-2):227-31
pubmed: 8394832
Curr Opin Neurol. 1997 Oct;10(5):436-42
pubmed: 9330892